Rapid Enantiomeric Excess Measurements of Enantioisotopomers by Molecular Rotational Resonance Spectroscopy
Originally Published in Organic Process Research & Development, March 2023
Authors: Reilly E. Sonstrom; Zoua Pa Vang; Haley N. Scolati; Justin L. Neill; Brooks H. Pate; Joseph R. Clark
Publication Summary
Originally published in Organic Process Research & Development, this publication demonstrates a high-throughput approach for measuring the enantiomeric excess (ee) of enantioisotopomers using molecular rotational resonance (MRR) spectroscopy. The work addresses an important analytical challenge associated with selectively deuterated molecules, which can exhibit chirality solely due to deuterium substitution and therefore require specialized methods for chiral analysis.
The researchers developed a cavity-enhanced MRR methodology that significantly reduces measurement time and sample consumption while maintaining accurate determination of enantiomeric excess. The approach also simplifies analysis by enabling the selection of monitoring transitions directly from broadband rotational spectra, supporting more efficient reaction optimization and characterization workflows for precision deuteration chemistry
Key Takeaways
-
MRR spectroscopy enables rapid measurement of enantiomeric excess in enantioisotopomers, supporting the characterization of molecules that are chiral due solely to deuterium substitution.
-
A cavity-enhanced MRR approach significantly reduces analysis time and sample consumption, improving the practicality of routine chiral analysis.
-
The method supports high-throughput workflows, making it well suited for reaction development and optimization studies.
-
Researchers can determine enantiomeric excess without extensive spectroscopic analysis, simplifying the process of monitoring stereochemical outcomes.
-
The work advances analytical capabilities for precision deuteration chemistry, where accurate assessment of stereoselectivity is essential.
-
Improved chiral analysis tools may help accelerate the development of selectively deuterated compounds for pharmaceutical and research applications.